MUTANT P53 PROTEIN ASSOCIATED WITH CHEMOSENSITIVITY IN BREAST-CANCER SPECIMENS

被引：53

作者：

KOECHLI, OR ^{[1
]}

SCHAER, GN ^{[1
]}

SEIFERT, B ^{[1
]}

HORNUNG, R ^{[1
]}

HALLER, U ^{[1
]}

EPPENBERGER, U ^{[1
]}

MUELLER, H ^{[1
]}

机构：

[1] UNIV BASEL,DEPT RES & GYNECOL,BIOMOLEC TUMOUR DIAGNOST UNIT,BASEL,SWITZERLAND

来源：

LANCET | 1994年 / 344卷 / 8937期

关键词：

D O I：

10.1016/S0140-6736(94)90447-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1647 / 1648

页数：2

共 5 条

[1] ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].

GANNON, JV ;

GREAVES, R ;

IGGO, R ;

LANE, DP .

EMBO JOURNAL, 1990, 9 (05) :1595-1602

[2]

GLEBOV OK, 1994, CANCER RES, V54, P3703

[3] APPLICATION OF THE ADENOSINE TRIPHOSPHATE-CELL VIABILITY ASSAY IN HUMAN BREAST-CANCER CHEMOSENSITIVITY TESTING - A REPORT ON THE 1ST RESULTS [J].

KOECHLI, OR ;

AVNER, BP ;

SEVIN, BU ;

AVNER, B ;

PERRAS, JP ;

ROBINSON, DS ;

AVERETTE, HE .

JOURNAL OF SURGICAL ONCOLOGY, 1993, 54 (02) :119-125

[4] CHARACTERISTICS OF THE COMBINATION PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER CELL-LINES ANALYZED WITH THE ATP-CELL VIABILITY ASSAY [J].

KOECHLI, OR ;

SEVIN, BU ;

PERRAS, JP ;

CHOU, TC ;

ANGIOLI, R ;

STEREN, A ;

UNTCH, M ;

AVERETTE, HE .

BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (01) :21-27

[5] P53 STATUS AND THE EFFICACY OF CANCER-THERAPY IN-VIVO [J].

LOWE, SW ;

BODIS, S ;

MCCLATCHEY, A ;

REMINGTON, L ;

RULEY, HE ;

FISHER, DE ;

HOUSMAN, DE ;

JACKS, T .

SCIENCE, 1994, 266 (5186) :807-810

← 1 →